Archon Biosciences

archon.bio

Biotechnology company developing AI-designed Antibody Cages to unlock powerful therapeutic targets for disease treatment.

Website LinkedIn Careers

Employees11-50

Funding$20M

Healthcare AIAI-EnhancedSeed$10M-$50M

About

Archon Biosciences is a biotechnology company that develops geometrically tunable protein therapeutics using AI-driven computational protein design. They create a new class of biologics called Antibody Cages (AbC) to target disease pathways that are currently undruggable. The company leverages generative AI to design and manufacture novel proteins for therapeutic applications.

Active Roles

No active roles right now.

Get notified when they post

Key Investors

Madrona Ventures, DUMAC Inc., Sahsen Ventures, WRF Capital, Pack Ventures, Alexandria Venture Investments, Cornucopian Capital